Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Legal Officer

Chief Executive Officer

Principal Accounting Officer

Chief Financial Officer

Chief Medical Officer

Chief Commercial Officer

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism. The company develops PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias; and AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular m...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-10	Premium	sold	Premium	Premium	Premium	-
2024-04-08	Premium	acquired	Premium	Premium	Premium	-
2024-03-07	Premium	sold	Premium	Premium	Premium	-
2024-03-06	Premium	sold	Premium	Premium	Premium	-
2024-03-05	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2024-03-05	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-03-05	Premium	sold	Premium	Premium	Premium	Principal Accounting Officer
2024-03-05	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-03-05	Premium	sold	Premium	Premium	Premium	Principal Accounting Officer
2024-03-05	Premium	sold	Premium	Premium	Premium	-
2024-03-05	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	Principal Accounting Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-02-27	Premium	acquired	Premium	Premium	Premium	-
2024-02-27	Premium	sold	Premium	Premium	Premium	-
2024-02-26	Premium	acquired	Premium	Premium	Premium	-
2024-02-26	Premium	sold	Premium	Premium	Premium	-
2024-02-23	Premium	sold	Premium	Premium	Premium	-
2024-02-23	Premium	acquired	Premium	Premium	Premium	-
2024-02-20	Premium	sold	Premium	Premium	Premium	Principal Accounting Officer
2024-02-14	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2024-02-14	Premium	sold	Premium	Premium	Premium	Chief Medical Officer

AGIO - Agios Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for AGIO